CLINICAL_TRIALS
trial_result
· 2023-08-18
Clinical Trial Update: Chemotherapy and Immunotherapy as Treatment for MSS Metastatic Colorectal Cancer With High Immune Infiltrate [Phase 2]
Summary
Phase 2 trial evaluating chemotherapy plus immunotherapy for microsatellite-stable metastatic colorectal cancer with high immune infiltrate.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Federation Francophone de Cancerologie Digestive | Conditions: Colorectal Cancer Metastatic, High Immune Infiltrate | Phase 2 | Status: UNKNOWN